Penumbra (PEN) Assets (QoQ) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Penumbra | 12.52 Bn | 11.91 Bn | 253.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.94% |
| Dec 31, 2025 | 4.71% |
| Sep 30, 2025 | 4.15% |
| Jun 30, 2025 | 5.12% |
| Mar 31, 2025 | 3.92% |
| Dec 31, 2024 | 3.65% |
| Sep 30, 2024 | -3.61% |
| Jun 30, 2024 | -2.87% |
| Mar 31, 2024 | 1.51% |
| Dec 31, 2023 | 5.99% |
| Sep 30, 2023 | 2.50% |
| Jun 30, 2023 | 2.67% |
| Mar 31, 2023 | 1.78% |
| Dec 31, 2022 | 3.73% |
| Sep 30, 2022 | -0.47% |
| Jun 30, 2022 | 2.02% |
| Mar 31, 2022 | 4.61% |
| Dec 31, 2021 | 27.85% |
| Mar 31, 2021 | 2.17% |
| Dec 31, 2020 | 1.56% |
| Sep 30, 2020 | 3.86% |
| Jun 30, 2020 | 17.46% |
| Mar 31, 2020 | -0.25% |
| Dec 31, 2019 | 8.42% |
| Sep 30, 2019 | 4.97% |
| Jun 30, 2019 | 2.87% |
| Mar 31, 2019 | 10.44% |
| Dec 31, 2018 | 2.79% |
| Sep 30, 2018 | 0.34% |
| Jun 30, 2018 | 1.96% |
| Mar 31, 2018 | 2.74% |
| Dec 31, 2017 | 3.83% |
| Sep 30, 2017 | 10.09% |
| Jun 30, 2017 | -0.33% |
| Mar 31, 2017 | 35.72% |
| Dec 31, 2016 | 3.69% |
| Sep 30, 2016 | 4.70% |
| Jun 30, 2016 | 3.21% |
| Mar 31, 2016 | 4.27% |
| Dec 31, 2015 | 1.74% |